Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
Hochhaus G, Chen MJ, Kurumaddali A, Schilling U, Jiao Y, Drescher SK, Amini E, Berger SM, Kandala B, Tabulov C, Shao J, Seay B, Abu-Hasan MN, Baumstein SM, Winner L, Shur J, Price R, Hindle M, Wei X, Carrasco C, Sandell D, Oguntimein O, Kinjo M, Delvadia R, Saluja B, Lee SL, Conti DS, Bulitta JB. Hochhaus G, et al. Among authors: schilling u. AAPS J. 2021 Mar 25;23(3):48. doi: 10.1208/s12248-021-00569-x. AAPS J. 2021. PMID: 33768368 Free PMC article. Clinical Trial.
Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
Hochhaus G, Chen MJ, Kurumaddali A, Schilling U, Jiao Y, Drescher SK, Amini E, Berger SM, Kandala B, Tabulov C, Shao J, Seay B, Abu-Hasan MN, Baumstein SM, Winner L, Shur J, Price R, Hindle M, Wei X, Carrasco C, Sandell D, Oguntimein O, Kinjo M, Delvadia R, Saluja B, Lee SL, Conti DS, Bulitta JB. Hochhaus G, et al. Among authors: schilling u. AAPS J. 2021 Nov 22;24(1):1. doi: 10.1208/s12248-021-00655-0. AAPS J. 2021. PMID: 34811595 No abstract available.
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays.
Amini E, Berger SM, Schilling U, Jiao Y, Chen MJ, Bachhav S, Baumstein SM, Tang Y, Al-Humiari M, Leon Astudillo CE, Drescher S, Iley T, Shur J, Price R, Carrasco C, Conti DS, Delvadia R, Oguntimein O, Witzmann K, Absar M, Luke MC, Boc S, Dhapare S, Saluja B, Bielski E, Newman B, Bulitta JB, Hochhaus G. Amini E, et al. Among authors: schilling u. Mol Pharm. 2023 Nov 6;20(11):5690-5700. doi: 10.1021/acs.molpharmaceut.3c00553. Epub 2023 Sep 29. Mol Pharm. 2023. PMID: 37773975 Clinical Trial.
35 results